Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

none 25 no Abstract OBJECTIVES: To evaluate the incidence and dose-dependency of mitoxantrone (MTX)-associated acute myelocytic leukemia (AML) in the network of Italian multiple sclerosis (MS) clinics. METHODS: We performed a multicenter retrospective cohort study of patients treated with MTX in MS centers under the Italian national health care system between 1998 and 2008. Demographic, disease, treatment, and follow-up information were collected using hospital records. RESULTS: Data were available for 3,220 patients (63% women) from 40 Italian centers. Follow-up (mean ± SD) was 49 ± 29 months (range 12-140 months). We observed 30 cases of AML (incidence 0.93% [95% confidence interval 0.60%…

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study

ObjectiveTo assess the effects of subcutaneous (sc) interferon (IFN) -1a on cognition over 5 years in mildly disabled patients with relapsing-remitting multiple sclerosis (RRMS).MethodsPatients aged 18-50 years with RRMS (Expanded Disability Status Scale score ≤4.0) who had completed the 3-year COGIMUS study underwent standardized magnetic resonance imaging, neurological examination, and neuropsychological testing at years 4 and 5. Predictors of cognitive impairment at year 5 were identified using multivariate analysis.ResultsOf 331 patients who completed the 3-year COGIMUS study, 265 participated in the 2-year extension study, 201 of whom (75.8%; sc IFN β-1a three times weekly: 44 µg, n = …

La Lepidotterofauna dei Biotopi della Riserva Naturale Orientata "Bosco della Ficuzza, Rocca Busambra, Bosco del Cappelliere e Gorgo del Drago"

Risultati preliminari del monitoraggio di lepidotteri diurni in un sito di interesse comunitario per differenti scopi applicativi

Durante il XX secolo e specialmente negli ultimi 50 anni è stato riportato un declino nel numero specie di lepidotteri diurni presenti in Europa, ed ad una modificazione delle comunità delle farfalle. Tale decremento è stato attributo a diversi fattori: frammentazione e la scomparsa degli habitat e l'intensificazione dell'agricoltura e delle pratiche ad essa connesse. L'introduzione di nuovi prodotti in agricoltura, quali ad esempio le piante geneticamente modificate o i prodotti a base di virus entomopatogeni hanno posto ancor più l'accento sulla necessità di monitorare i lepidotteri non target (principalmente i diurni) sia come data set iniziale sia per i piani di post monitoring. A tal f…

Preliminary selection of non-target Lepidoptera species for ecological risk assessment of Bt canola in Sicily

It is essential to assess the environmental risk that Bt canola resistant to Lepidopteran pests may hold and to study its effect on species assemblages that fulfil a variety of ecosystem functions. Environmental risk assessment can be improved through the use of an ecological model which can be applied to a specific environment, so that local species can be classified functionally and prioritized to identify potential test species. Several other Lepidoptera species are also directly exposed to Bt toxin. In this paper an ecological approach was followed for selection of non-target Lepidoptera species for ecological risk assessment of Bt canola in Sicily, using data collected over a one-year …

Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.

Background Cognitive impairment is a common symptom of multiple sclerosis (MS), but the association between cognitive impairment and magnetic resonance imaging (MRI) disease measures in patients with relapsing–remitting (RR) MS is unclear. Objectives To study the prevalence of cognitive impairment and its relation with MRI disease measures in mildly disabled patients with RRMS. Methods Patients aged 18–50 years with RRMS (McDonald criteria) and an Expanded Disability Status Scale (EDSS) score ≤4.0, who were enrolled in the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study, underwent baseline standardized MRI complete neurological examination and neuropsychological testing. Results…